LORENZI, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 452
EU - Europa 82
AS - Asia 38
Continente sconosciuto - Info sul continente non disponibili 1
Totale 573
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 452
IT - Italia 37
CN - Cina 29
SE - Svezia 15
FI - Finlandia 11
GB - Regno Unito 8
DE - Germania 6
TW - Taiwan 4
IN - India 3
IE - Irlanda 2
NL - Olanda 2
TR - Turchia 2
EU - Europa 1
PL - Polonia 1
Totale 573
Salva come PNG Salva come JPEG
Città #
Fairfield 75
Chandler 61
Ashburn 38
Woodbridge 38
Cambridge 30
Houston 30
Seattle 20
Padova 15
Wilmington 14
San Diego 13
Beijing 10
Helsinki 10
Ann Arbor 9
Medford 8
Princeton 8
Des Moines 6
New York 5
Columbus 4
Hsinchu County 4
Washington 4
London 3
Milan 3
Pune 3
Roxbury 3
Amsterdam 2
Belluno 2
Castagnole 2
Dublin 2
Duncan 2
Guangzhou 2
Ogden 2
Pignone 2
Portland 2
Treviso 2
Ankara 1
Castelfranco Veneto 1
Hounslow 1
Kilburn 1
Los Angeles 1
Maida Vale 1
Orange 1
Santa Clara 1
Seregno 1
Shanghai 1
Torreglia 1
Zonguldak 1
Totale 446
Salva come PNG Salva come JPEG
Nome #
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations 118
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 76
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study 72
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 64
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI) 62
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 60
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 57
Extraskeletal Myxoid Chondrosarcoma: clinical and molecular characteristics and outcomes of patients treated at two Institutions 50
Diagnostic-Therapeutic Pathway and Outcomes of Early Stage NSCLC: a Focus on EGFR Testing in the Real-World 15
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab 13
Totale 587
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.914
article - articoli 2.914
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 0 3 4 4
2019/202037 4 1 0 1 2 3 2 2 4 4 10 4
2020/202167 7 3 13 2 4 2 1 8 4 9 1 13
2021/2022195 3 16 34 11 14 32 25 7 9 8 8 28
2022/2023139 17 21 6 19 10 13 2 14 29 3 5 0
2023/2024115 13 13 17 11 10 29 11 4 3 4 0 0
Totale 587